Primer: MorphoSys AG (MOR US) - Aug 2026
MorphoSys is in the process of being acquired by Novartis for €2.7 billion (€68 per share), a deal driven by the potential of its late-stage...
101 Views
Primer: MorphoSys AG (MOR GR) - Mar 2026
MorphoSys is pending acquisition by Novartis for €2.7 billion (€68 per share), a deal driven by the potential of its late-stage oncology asset,...
194 Views